CSGH yields 20000000.00% · PFE yields 6.20%● Live data
📍 CSGH pulled ahead of the other in Year 1
Combined, CSGH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSGH + PFE for your $10,000?
China Sun Group High-Tech Co., through its subsidiary, Dalian Xinyang High-Tech Development Co. Ltd., engages in the production and sale of cobaltosic oxide and lithium cobalt oxide used in lithium ion rechargeable batteries in the People's Republic of China and internationally. It provides battery level cobaltosic oxide, a cathode material used in the manufacturing of lithium cobalt oxide; and lithium iron phosphate, a cathode material used in lithium iron phosphate batteries. The company also offers ternary cathode material, which is applied as the main cathodes of small-sized communication and power instruments, such as portable power tools, electronic apparatus, laptops, and video cameras, as well as electric autos and bicycles. It serves lithium ion battery manufacturers, end product users, and lithium series product manufacturers. The company was formerly known as Capital Resource Funding, Inc. and changed its name to China Sun Group High-Tech Co. in August 2007. China Sun Group High-Tech Co. is headquartered in Dalian, the People's Republic of China.
Full CSGH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.